Fig. 2From: Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims dataCox proportional hazard regression model for the comparison of low-dose DOAC versus phenprocoumon. Adjusted hazard ratios with 95%-confidence interval and p-value adjusted with Bonferroni correction (adjusted p-value < .003, n = 15)Back to article page